$1.87
0.042.19%
Last update: Nov 9, 5:52 AM
Medicus Pharma Ltd (MDCX) Stock Price, Quote, News & History
MDCXNASDAQ
Medicus Pharma advances its Pfizer-partnered cancer asset and plans a $135 million SkinJect SPAC deal while reducing quarterly operating expenses.
You can purchase shares of Medicus Pharma (NASDAQ:MDCX) through any online brokerage.
Other companies in Medicus Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Medicus Pharma has a consensus price target of $725.00.
The stock price for Medicus Pharma (NASDAQ: MDCX) is $1.78 last updated November 9, 2026 at 5:52 AM EST.
There are no upcoming dividends for Medicus Pharma.
Medicus Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Medicus Pharma.
Medicus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
